These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26375434)

  • 1. Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Sep; 57(1478):133-5. PubMed ID: 26375434
    [No Abstract]   [Full Text] [Related]  

  • 2. Addendum: Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529137
    [No Abstract]   [Full Text] [Related]  

  • 3. U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
    Puppo G; Puppo V
    Eur Urol; 2016 Feb; 69(2):379-80. PubMed ID: 26455357
    [No Abstract]   [Full Text] [Related]  

  • 4. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

  • 5. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flibanserin.
    Vallejos X; Wu C
    J Pharm Pract; 2017 Apr; 30(2):256-260. PubMed ID: 26873507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z; Yang D; Yu L; Cui Y
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 12. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA; Kingsberg SA; Shumel B; Hanes V; Garcia M; Sand M
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
    Fisher WA; Pyke RE
    Sex Med Rev; 2017 Oct; 5(4):445-460. PubMed ID: 28666836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flibanserin for female sexual dysfunction.
    Reviriego C
    Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of flibanserin "new female Viagra
    Terrier C; Terrier JE
    Prog Urol; 2016; 26(11-12):592-599. PubMed ID: 27663307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.